Embolectomy Plus TEVAR in Advanced Stage Aortic Angiosarcoma with Acute Limb Ischemia: A Case Report

Authors

  • Phongthorn Tuntivararut

Keywords:

Acute limb ischemia, adrenal metastasis, aortic angiosarcoma, TEVAR

Abstract

Objective: To report the case of primary aortic angiosarcoma with bilateral adrenal metastasis coming with acute limb ischemia, including the management and pathological report.
Case presentation: A 54 year-old female came to the hospital because of her back pain. CTA of the whole aorta revealed the posterior mediastinal mass invaded the aorta, bilateral adrenal mass and renal infarction. She was sent for endoscopic ultrasonography (EUS) with fine needle aspiration (FNA) at the mediastinal mass and adrenal mass. During
the hospitalization, the patient developed acute limb ischemia on her right leg. CTA of the both legs showed absence of the distal run-off from the right common iliac artery. We performed femoral embolectomy and TEVAR. Pathological report showed malignant spindle cells and the immunohistochemistry suspected the angiosarcoma of the aorta.
Conclusion: Primary aortic angiosarcoma is a very rare disease. There is no consistent approach to the management due to its rarity.

Downloads

Published

20-09-2017

How to Cite

Tuntivararut, P. (2017). Embolectomy Plus TEVAR in Advanced Stage Aortic Angiosarcoma with Acute Limb Ischemia: A Case Report. Siriraj Medical Journal, 69(5), 306–309. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/99637

Issue

Vol. 69 No. 5 (2017): September-October

Section

Case Report

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.